GlassScriptPhysician profile
Christopher R Jacobs
NPI 1164872412
$8,029.48
in general payments reported to CMS, 2019-2025
12 companies · $1,312 in 2025
The $1,312 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,552 · 2023: $2,712 · 2024: $1,454 · 2025: $1,312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,908 · Travel and Lodging: $1,570 · Grant: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,907.64 |
| Travel and Lodging | $1,570.24 |
| Grant | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,626.14 | 2021-2025 | Pivox Oblique Lateral Spinal System |
| Silk Road Medical, INC. | $1,999.28 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| W. L. Gore & Associates, INC. | $924.92 | 2023-2025 | Gore Synecor Biomaterial, Gore Tag Thoracic Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Bolton Medical INC | $507.77 | 2024-2025 | Treo Abdominal Stent-Graft System |
| Lemaitre Vascular, INC. | $274.39 | 2024-2025 | Hydro Lemaitre Valvulotome, Restoreflow, Artegraft Vascular Graft |
| Integra Lifesciences Corporation | $173.41 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $162.63 | 2023 | Renasys Touch, Pico 14 |
| Cardiva Medical, INC. | $123.48 | 2024 | Cardiva Vascade 6/7f Vcs |
| Gilead Sciences, INC. | $84.72 | 2024 | |
| Ge Healthcare | $84.43 | 2024 | |
| Penumbra, INC. | $46.33 | 2024 | Indigo System |
| Cook Medical LLC | $21.98 | 2024 | Zilver Ptx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Jacobs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.